MyAverix Finance
SHG · Healthcare
Hunan Nucien Pharmaceutical Co Ltd (688189)
Biotechnology
Hunan Nucien Pharmaceutical Co Ltd (688189) is listed on SHG in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $2.11B, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 688189
Hunan Nucien Pharmaceutical Co Ltd (688189) — FAQ
What is Hunan Nucien Pharmaceutical Co Ltd's market cap?
Hunan Nucien Pharmaceutical Co Ltd (688189) has a reported market cap of $2.11B (data as of 2026-03-29).
What is 688189's P/E ratio?
The price-to-earnings (P/E) ratio for Hunan Nucien Pharmaceutical Co Ltd (688189) is 18.00 (data as of 2026-03-29).
Does Hunan Nucien Pharmaceutical Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Hunan Nucien Pharmaceutical Co Ltd (688189). Check the MyAverix Finance app for the latest dividend data.
What sector is Hunan Nucien Pharmaceutical Co Ltd in?
Hunan Nucien Pharmaceutical Co Ltd (688189) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 688189 listed on?
688189 is listed on SHG.
What is Hunan Nucien Pharmaceutical Co Ltd's net margin?
Hunan Nucien Pharmaceutical Co Ltd (688189) reports a net margin of 0.0% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.